These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30468830)

  • 1. Lyophilization Process Design and Development: A Single-Step Drying Approach.
    Pansare SK; Patel SM
    J Pharm Sci; 2019 Apr; 108(4):1423-1433. PubMed ID: 30468830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallizing amino acids as bulking agents in freeze-drying.
    Horn J; Tolardo E; Fissore D; Friess W
    Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Optical Coherence Tomography Freeze-Drying Microscopy for Designing Lyophilization Process and Its Impact on Process Efficiency and Product Quality.
    Korang-Yeboah M; Srinivasan C; Siddiqui A; Awotwe-Otoo D; Cruz CN; Muhammad A
    AAPS PharmSciTech; 2018 Jan; 19(1):448-459. PubMed ID: 28785859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
    Horn J; Schanda J; Friess W
    Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing lyophilization primary drying: A vaccine case study with experimental and modeling techniques.
    Najarian J; Metsi-Guckel E; Renawala HK; Grosse D; Sims A; Walter A; Sarkar A; Karande A
    Int J Pharm; 2024 Jun; 659():124168. PubMed ID: 38663644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyophilization of Small-Molecule Injectables: an Industry Perspective on Formulation Development, Process Optimization, Scale-Up Challenges, and Drug Product Quality Attributes.
    Butreddy A; Dudhipala N; Janga KY; Gaddam RP
    AAPS PharmSciTech; 2020 Sep; 21(7):252. PubMed ID: 32885357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of temperature ramp rate during the primary drying process on the properties of amorphous-based lyophilized cake, Part 2: Successful lyophilization by adopting a fast ramp rate during primary drying in protein formulations.
    Ohori R; Akita T; Yamashita C
    Eur J Pharm Biopharm; 2018 Sep; 130():83-95. PubMed ID: 29913271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated process analytical technology (PAT) approach to monitoring the effect of supercooling on lyophilization product and process parameters of model monoclonal antibody formulations.
    Awotwe Otoo D; Agarabi C; Khan MA
    J Pharm Sci; 2014 Jul; 103(7):2042-2052. PubMed ID: 24840395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamentals of freeze-drying.
    Nail SL; Jiang S; Chongprasert S; Knopp SA
    Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a temperature ramp approach (TRA) to design an optimum and robust freeze-drying process for pharmaceutical formulations.
    Assegehegn G; Brito-de la Fuente E; Franco JM; Gallegos C
    Int J Pharm; 2020 Mar; 578():119116. PubMed ID: 32027958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of primary drying temperature on process efficiency and product performance of lyophilized Ertapenam sodium.
    Vohra ZA; Zode SS; Bansal AK
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1940-1948. PubMed ID: 31625418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive conditions during primary drying as a contemporary approach to optimise freeze-drying cycles of biopharmaceuticals.
    Bjelošević M; Seljak KB; Trstenjak U; Logar M; Brus B; Ahlin Grabnar P
    Eur J Pharm Sci; 2018 Sep; 122():292-302. PubMed ID: 30006178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyophilization cycle development for a high-concentration monoclonal antibody formulation lacking a crystalline bulking agent.
    Colandene JD; Maldonado LM; Creagh AT; Vrettos JS; Goad KG; Spitznagel TM
    J Pharm Sci; 2007 Jun; 96(6):1598-608. PubMed ID: 17117409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannitol-sucrose mixtures--versatile formulations for protein lyophilization.
    Johnson RE; Kirchhoff CF; Gaud HT
    J Pharm Sci; 2002 Apr; 91(4):914-22. PubMed ID: 11948529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization of Cyclophosphamide Monohydrate During Lyophilization.
    Munjal B; Zode SS; Bansal AK
    J Pharm Sci; 2019 Mar; 108(3):1195-1202. PubMed ID: 30352215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finite Element Method (FEM) Modeling of Freeze-drying: Monitoring Pharmaceutical Product Robustness During Lyophilization.
    Chen X; Sadineni V; Maity M; Quan Y; Enterline M; Mantri RV
    AAPS PharmSciTech; 2015 Dec; 16(6):1317-26. PubMed ID: 25791415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of freeze-drying cycle via design space approach: a case study on vaccines.
    Scutellà B; Bourlès E
    Pharm Dev Technol; 2020 Dec; 25(10):1302-1313. PubMed ID: 32752908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-plate freeze-drying: a high throughput platform for screening of physical properties of freeze-dried formulations.
    Trnka H; Rantanen J; Grohganz H
    Pharm Dev Technol; 2015 Jan; 20(1):65-73. PubMed ID: 24417680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nonsteady state modeling of freeze drying: in-process product temperature and moisture content mapping and pharmaceutical product quality applications.
    Pikal MJ; Cardon S; Bhugra C; Jameel F; Rambhatla S; Mascarenhas WJ; Akay HU
    Pharm Dev Technol; 2005; 10(1):17-32. PubMed ID: 15776810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.